Buy 5 or more, save 35% · code

Back to Catalog

Small Molecules

BAM15 (50mg Per Capsule)

$280Per Unit

Research-grade capsules with verified potency and pharmaceutical-grade encapsulation for institutional protocols.

Lot BAM2025-14A · COA on request
50mg capsules, 30-count bottle
Room temperature, dry location

1 × $280.00 = $280.00

4 more units of anything - mix and match - unlocks 35% off with code EHAB35.

BAM15 (50mg Per Capsule)

$280.00

Research use only
BAM15 (50mg Per Capsule) research packaging
50mg capsules, 30-count bottle
Anubis Research Labs

Documentation

The certificate of analysis for the current lot (Lot BAM2025-14A) is sent on request, so you can review identity and purity testing before you order.

Request the lot COA

Research summary

BAM15

Regulatory status
Experimental compound with no human trials identified.
Strongest evidence
Animal and cell studies only
Overview

BAM15 is a small-molecule mitochondrial uncoupler: it lets mitochondria burn fuel without making as much ATP, raising energy expenditure in models.

What researchers study it for
  • Diet-induced obesity (mice)
  • Fatty liver, sepsis and kidney-injury models
Mechanism

Mitochondria-targeted protonophore that increases respiration and activates AMPK in cells.

Evidence (2)
  1. Animal study

    Obesity and glycemic control (EMBO Mol Med 2020)

    Mice treated with BAM15 resisted diet-induced weight gain and had improved glycemic control.[1]

  2. Animal study

    Sepsis and kidney injury (J Clin Invest 2023)

    Treated mouse sepsis and kidney-injury models.[2]

Limitations of the evidence
  • Uncouplers as a class include compounds with serious toxicity in humans; BAM15 safety in people is unknown.
  • Products on this site are sold for laboratory research only. They are not the medicines used in the trials above, and those results do not apply to research material.
Sources (2)
  1. 1.BAM15-mediated mitochondrial uncoupling protects against obesity and improves glycemic controlAxelrod CL et al. EMBO Mol Med. 2020 Animal study
  2. 2.BAM15 treats mouse sepsis and kidney injury, linking mortality, mitochondrial DNA, tubule damage, and neutrophilsTsuji N et al. J Clin Invest. 2023 Animal study
Every published studyPubMed search: BAM15(opens in a new tab)Every registered trialClinicalTrials.gov search: BAM15(opens in a new tab)

Reviewed 2026-10-02. Summaries describe published research and regulatory records; they are not medical advice and do not describe how to use this product. Sold for laboratory research use only.